Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The FDA has given 510(k) clearance to an AI alert for urgent finding of a collapsed lung in chest X-rays. The approval is a first for an AI-based chest X-ray solution that can help doctors make quicker diagnoses from one of the world’s most used imaging modalities.
AI can predict death or heart attack better than humans, according to a new study presented at the International Conference on Nuclear Cardiology and Cardiac CT (ICNC) in Lisbon.
Combing through insurance claims and other health data on more than 72 million U.S. residents, a machine learning algorithm was able to quite accurately identify more than 222,000 individuals who have very early stage Alzheimer’s disease.
As medical devices are increasingly being touched by new AI innovations, the FDA will soon have to grapple with reality of regulating “living things” in a new way, according to a report from Roll Call.
The global excitement around healthcare’s embrace of AI and other developing technologies is not misplaced, but it needs to be tempered by an ongoing watchfulness for misuse.
Over the next 50 to 100 years, quantum computing will increasingly automate all manner of healthcare processes while biomaterials and genetic engineering drive regenerative medicine into everyday care.
